Leukotriene receptor antagonists are not as effective as intranasal corticosteroids for managing nighttime symptoms of allergic rhinitis [4]

Journal of Allergy and Clinical Immunology

Volumn 116, Issue 2, 2005, Pages 463-464

  Nathan, Robert A ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; FLUTICASONE PROPIONATE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LORATADINE; MONTELUKAST; PLACEBO; POLLEN ANTIGEN;

ALLERGIC RHINITIS; AROUSAL; CELL COUNT; CHRONOTHERAPY; CIRCADIAN RHYTHM; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; EOSINOPHIL; FATIGUE; HAY FEVER; HUMAN; LETTER; NASAL BIOPSY; NIGHT; NOSE CONGESTION; PARALLEL DESIGN; PERENNIAL RHINITIS; POLLEN; PRIORITY JOURNAL; RISK FACTOR; SLEEP DISORDER; SLEEP DISORDERED BREATHING; SOMNOLENCE; SYMPTOM;

ACETATES; ADMINISTRATION, INTRANASAL; ANDROSTADIENES; CIRCADIAN RHYTHM; DOUBLE-BLIND METHOD; HUMANS; LEUKOTRIENE ANTAGONISTS; QUINOLINES; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL;

EID: 23244457251     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2005.03.045     Document Type: Letter

References (6)

1. Meltzer EO, editor. Allergic rhinitis after hours: the relevance and consequence of nighttime symptoms. J Allergy Clin Immunol 2004;114:S133-S153.
2. G. Philip, K. Malmstrom, F.C. Hampel, S.F. Weinstein, C.F. LaForce, and P.H. Ratner Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring Clin Exp Allergy 32 2002 1020 1028
3. A.S. Nayak, G. Philip, S. Lu, M.-P. Malice, and T.F. Reiss Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall Ann Allergy Asthma Immunol 88 2002 592 600
4. J. van Adelsberg, G. Phillip, C.F. LaForce, S.F. Weinstein, J. Menten, and M.-P. Malice Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis Ann Allergy Asthma Immunol 90 2003 214 222
5. P.H. Ratner, W.C. Howland, R. Arastu, E.E. Philpot, K.C. Klein, and C.A. Baidoo Fluticasone propionate aqueous nasal spray provided greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast Ann Allergy Asthma Immunol 90 2003 536 542
6. T. Pullerits, L. Praks, V. Ristioja, and J. Lotvall Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis J Allergy Clin Immunol 109 2002 949 955